Do glucocorticoid steroids lower the erythrocyte sedimentation rate (ESR) and how should ESR be interpreted in patients receiving steroids?

ESR is Affected by Steroids

Yes, glucocorticoid steroids significantly lower ESR, and this effect can mask disease activity, making ESR an unreliable marker for monitoring inflammatory conditions in patients receiving steroid therapy.

How Steroids Affect ESR

Glucocorticoids suppress ESR through their anti-inflammatory effects, and this occurs even at low doses. The suppression is substantial—studies show ESR can drop by approximately 46% within one week of steroid administration 1. This effect:

• Occurs with both oral and intra-articular steroid injections 1
• Persists for variable periods up to 6 months after injection 1
• Happens even with low-dose therapy (as little as 5 mg/day prednisolone can significantly decrease ESR) 2
• Can normalize ESR even when underlying disease remains active 3, 4

Critical Clinical Implications

In Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)

ESR becomes particularly unreliable once steroid therapy begins:

• Most patients with temporal arteritis who have low ESR (<50 mm/h) have either received prior steroid therapy or have a history of polymyalgia rheumatica 3
• In the tocilizumab trials for GCA, 92% of disease flares in steroid-treated patients occurred with normal CRP levels, demonstrating that acute phase reactants lose reliability during treatment 5
• ESR can normalize with glucocorticoid treatment while other markers of inflammation (like von Willebrand factor) remain elevated, indicating persistent vascular inflammation 4

Practical Monitoring Guidance

When interpreting ESR in steroid-treated patients:

1. Do not rely on ESR alone to assess disease activity or guide treatment decisions 6, 5

2. Clinical symptoms are paramount—relapses can occur with normal ESR, particularly in patients on steroids 6, 5

3. Consider the timing:

   • ESR suppression begins within days of steroid initiation 1
   • The effect persists even after ESR "normalizes" 4
   • Many flares occur while patients are still taking prednisone (median 2-5 mg/day) despite normal inflammatory markers 5

4. In PMR/GCA specifically: High baseline ESR (>40 mm/h) is associated with higher relapse risk 7, but once treatment starts, normal ESR does not exclude active disease or relapse 6, 5

Alternative Approaches

For patients on chronic steroid therapy:

• Prioritize clinical assessment over laboratory markers 6
• Recognize that increment in acute phase reactants doesn't always reflect disease activity (can be infection or other conditions) 6
• Conversely, normal ESR/CRP does not exclude relapse, especially in steroid-treated patients 6, 5
• CRP may be slightly more reliable than ESR in some contexts 8, but both are affected by steroids

Common Pitfalls to Avoid

1. Never assume normal ESR means disease control in a patient receiving steroids—this is the most dangerous error
2. Don't increase steroids based solely on ESR elevation without clinical correlation (could be unrelated infection or inflammation) 6
3. Don't withhold temporal artery biopsy because ESR is normal in a patient with suspected GCA who has received steroids 3
4. In clinical trials, failure to account for steroid injections when using ESR as an outcome measure can confound results 1

The bottom line: In steroid-treated patients, clinical judgment trumps ESR values. A normal ESR provides false reassurance, while an elevated ESR requires clinical correlation before treatment escalation.